Assessing implementation fidelity of an on-site pharmacist intervention within Australian residential aged care facilities: A mixed methods study.
Aged care
Implementation fidelity
Intervention delivery
On-site pharmacist
Pharmacist
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
28
11
2022
accepted:
18
10
2023
medline:
30
10
2023
pubmed:
28
10
2023
entrez:
27
10
2023
Statut:
epublish
Résumé
An on-site pharmacist (OSP) intervention was implemented which sought to improve medication management within residential aged care facilities (RACFs) in the Australian Capital Territory, Australia. The objectives of this mixed methods study were to evaluate the implementation fidelity of the OSP intervention and to determine the moderating factors which influenced delivery of this intervention. This convergent parallel mixed methods study was underpinned by Hasson's conceptual framework for implementation fidelity. Implementation fidelity for seven intervention RACFs was quantitatively assessed using three quantitative data sets: (1) range of OSP intervention activities delivered; (2) random sample of 10% of medication reviews assessed for quality; (3) proportion of residents who received at least one medication review. Semi-structured interviews (n = 14) with managers and OSPs across the intervention RACFs were conducted to identify moderating factors which may have influenced OSP intervention delivery. The OSP intervention was generally delivered as intended with overall medium levels of implementation fidelity. This delivery was supported by a range of facilitation strategies with most participants perceiving that the intervention was delivered to a high standard. RACF managers and OSPs were mostly well engaged and responsive. A number of potential barriers (including the part-time OSP role, COVID-19 pandemic, RACFs spread out over a large area with significant distance between resident dwellings) and facilitators (including the pharmacist support meetings, OSPs who took time to establish relationships, RACF managers who actively supported OSPs and worked with them) for OSP intervention delivery were identified which have potential implications for the roll out of OSPs within Australian RACFs. In this study, the implementation fidelity of OSP intervention delivery was assessed with overall medium levels of fidelity found across the intervention RACFs. This suggested that the OSP intervention can generally be delivered as intended in real world RACFs. OSP intervention delivery was influenced by a range of moderating factors, some of which posed barriers and others which facilitated the OSP intervention being delivered as intended.
Sections du résumé
BACKGROUND
BACKGROUND
An on-site pharmacist (OSP) intervention was implemented which sought to improve medication management within residential aged care facilities (RACFs) in the Australian Capital Territory, Australia. The objectives of this mixed methods study were to evaluate the implementation fidelity of the OSP intervention and to determine the moderating factors which influenced delivery of this intervention.
METHODS
METHODS
This convergent parallel mixed methods study was underpinned by Hasson's conceptual framework for implementation fidelity. Implementation fidelity for seven intervention RACFs was quantitatively assessed using three quantitative data sets: (1) range of OSP intervention activities delivered; (2) random sample of 10% of medication reviews assessed for quality; (3) proportion of residents who received at least one medication review. Semi-structured interviews (n = 14) with managers and OSPs across the intervention RACFs were conducted to identify moderating factors which may have influenced OSP intervention delivery.
RESULTS
RESULTS
The OSP intervention was generally delivered as intended with overall medium levels of implementation fidelity. This delivery was supported by a range of facilitation strategies with most participants perceiving that the intervention was delivered to a high standard. RACF managers and OSPs were mostly well engaged and responsive. A number of potential barriers (including the part-time OSP role, COVID-19 pandemic, RACFs spread out over a large area with significant distance between resident dwellings) and facilitators (including the pharmacist support meetings, OSPs who took time to establish relationships, RACF managers who actively supported OSPs and worked with them) for OSP intervention delivery were identified which have potential implications for the roll out of OSPs within Australian RACFs.
CONCLUSION
CONCLUSIONS
In this study, the implementation fidelity of OSP intervention delivery was assessed with overall medium levels of fidelity found across the intervention RACFs. This suggested that the OSP intervention can generally be delivered as intended in real world RACFs. OSP intervention delivery was influenced by a range of moderating factors, some of which posed barriers and others which facilitated the OSP intervention being delivered as intended.
Identifiants
pubmed: 37891564
doi: 10.1186/s12913-023-10172-9
pii: 10.1186/s12913-023-10172-9
pmc: PMC10604517
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1166Informations de copyright
© 2023. The Author(s).
Références
Res Social Adm Pharm. 2022 Oct;18(10):3714-3723
pubmed: 35581128
Trials. 2020 May 29;21(1):439
pubmed: 32471514
J Rehabil Med. 2014 Jul;46(7):609-15
pubmed: 24940792
J Clin Pharm Ther. 2007 Apr;32(2):113-21
pubmed: 17381661
Clin Psychol Rev. 2011 Feb;31(1):79-88
pubmed: 21130938
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Curr Pharm Teach Learn. 2020 Jan;12(1):8-13
pubmed: 31843169
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Res Social Adm Pharm. 2022 Mar;18(3):2367-2391
pubmed: 33926827
Cochrane Database Syst Rev. 2016 Feb 12;2:CD009095
pubmed: 26866421
Int J Pharm Pract. 2014 Feb;22(1):96-100
pubmed: 23419033
BMC Health Serv Res. 2020 May 24;20(1):452
pubmed: 32448283
Sci Rep. 2020 Jun 23;10(1):10170
pubmed: 32576947
Implement Sci. 2009 Jul 14;4:38
pubmed: 19594942
Implement Sci. 2021 May 12;16(1):52
pubmed: 33980251
Int J Clin Pharm. 2019 Aug;41(4):1031-1046
pubmed: 31093942
Trials. 2019 Nov 28;20(1):656
pubmed: 31779684
Int J Environ Res Public Health. 2021 May 27;18(11):
pubmed: 34072223
J Clin Pharm Ther. 2019 Aug;44(4):595-602
pubmed: 30793340
Implement Sci Commun. 2020 Oct 08;1:88
pubmed: 33043302
J Clin Pharm Ther. 2022 Jul;47(7):1049-1069
pubmed: 35306683
Trials. 2021 Jun 11;22(1):390
pubmed: 34116708
Int J Clin Pharm. 2018 Jun;40(3):550-565
pubmed: 29556930
Res Social Adm Pharm. 2022 Oct;18(10):3766-3774
pubmed: 35581127
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Pharmacy (Basel). 2020 Aug 12;8(3):
pubmed: 32806701
J Am Med Dir Assoc. 2016 Sep 1;17(9):862.e1-9
pubmed: 27473899
BMC Med Res Methodol. 2019 Mar 15;19(1):59
pubmed: 30876403
Int J Integr Care. 2018 Apr 18;18(2):4
pubmed: 30127688
Age Ageing. 2023 Aug 1;52(8):
pubmed: 37598408
Res Nurs Health. 2010 Apr;33(2):164-73
pubmed: 20198637
J Clin Nurs. 2021 Mar;30(5-6):676-686
pubmed: 33295051
Implement Sci. 2010 Sep 03;5:67
pubmed: 20815872
Drugs Aging. 2022 Oct;39(10):773-794
pubmed: 36194370
Int J Clin Pharm. 2016 Jun;38(3):655-62
pubmed: 26846316
Pilot Feasibility Stud. 2019 Jul 11;5:89
pubmed: 31338204